Go to the main content area
:::
Sign in
Newsletter
Site Map

News
Database
Startup Ecosystem
Investment Deals
Startups
Investors
Research
Events
About Us
Sign in Newsletter Site Map 繁體中文 日本語

Database

Startups

BluSense Biotech Co., Ltd.

BluSense Biotech Co., Ltd.

Update：2026/09/15
Industries
Health Care Biotechnology Health Diagnostics mHealth Optoelectronics
Add to Favorites Edit
About
Financials
Patent
News
Main Industry
Health Care
Main Product/Service
Diagnostic platform for infectious diseases such as Dengue and Zika
(The content above was translated by AI.)
Founded Year
2015
Unified Business No.
42826243
Status
Active
Number of Employees
0
Total Paid-in Capital
0 (NT$)
Location of Company
Taiwan , Taoyuan City
Website
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
BluSense Diagnostics is a MedTech company developing a point-of-care blood testing device for infectious diseases.



more ↓

Similar Companies

Medimaging Integrated Solution Inc.

1. Horus Scope
2. Smart Solutions
3. Endoscopy
4. Micro Camera Modules
Health Care Artificial Intelligence (AI) Camera Digital Health Health Diagnostics Image Recognition Medical Device Optoelectronics

IXENSOR CO., LTD.

1. PixoTest® POCT COVID-19 Antigen Test
2. PixoTest® Blood Glucose Monitoring System
3. PixoTest® POCT System for HbA1c, Lipid Panel
4. Eveline® Smart Fertility System
5. Eveline‧Care Telehealth Platform
6. PixoTech® Platform
Health Care Biotechnology Health Diagnostics Medical Device mHealth Mobile Apps Quantified Self

CELLMAX TAIWAN CO. LTD.

1. FirstSight
2. CMx Platform
Health Care Bioinformatics Biotechnology Genetics Health Diagnostics Oncology

Precision Biotech

"AI-Screening" is an AI-powered biomedical interpretation system developed by Precision Biotech. It accelerates the identification of cardiovascular disease biomarkers, assists doctors and patients in obtaining comprehensive systemic cardiovascular hotspot analysis reports, and provides big data-driven analytical recommendation reports. The AI system can also analyze the relationship between daily diet and cardiovascular indices. This product has won the CES Taiwan Best Product Award and has completed clinical validation across medical institutions.

"BD-CARdio" is an ECG-AI interpretation system developed by Precision Biotech. It accelerates the generation of auxiliary analysis reports for cardiovascular diseases, assists doctors and patients in obtaining analysis reports for conditions such as arrhythmia, and provides big data-driven analytical recommendation reports. This product has completed clinical validation across four medical institutions and has successively won the Innovation Research Award from the Ministry of Economic Affairs and the Taipei Biotech Award.
(The content above was translated by AI.)
Health Care Artificial Intelligence (AI) Digital Health Health Diagnostics mHealth Mobile Apps Quantified Self